Granahan Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-355,360
| Closed | -$4.08M | – | 197 |
|
|
2023
Q3 | $4.08M | Buy |
355,360
+66,433
| +23% | +$762K | 0.15% | 137 |
|
|
2023
Q2 | $7.31M | Buy |
288,927
+45,465
| +19% | +$1.15M | 0.23% | 108 |
|
|
2023
Q1 | $7.84M | Sell |
243,462
-104,602
| -30% | -$3.37M | 0.24% | 101 |
|
|
2022
Q4 | $6.43M | Buy |
348,064
+103,147
| +42% | +$1.9M | 0.2% | 114 |
|
|
2022
Q3 | $6.61M | Buy |
244,917
+21,286
| +10% | +$575K | 0.22% | 115 |
|
|
2022
Q2 | $3.09M | Buy |
223,631
+61,936
| +38% | +$856K | 0.11% | 145 |
|
|
2022
Q1 | $3.15M | Sell |
161,695
-54,802
| -25% | -$1.07M | 0.08% | 154 |
|
|
2021
Q4 | $3.53M | Buy |
216,497
+88,258
| +69% | +$1.44M | 0.07% | 165 |
|
|
2021
Q3 | $3.57M | Buy |
+128,239
| New | +$3.57M | 0.07% | 168 |
|